Most lately, it has been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in related regions as classical opioid receptors, it binds to your big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts for a scavenger and does not activate a 2nd